• Moderators, please send me a PM if you are unable to access mod permissions. Thanks, Habsy.

Hey Nerds: Blockchain

Hope it works out for you! I've actually been thinking about grabbing an ETF that tied directly to ETH/BTC. ETHX.B is something I might grab when it cools down a bit.
 
I still have my ETH that I bought a while ago. Not sure whether it's worth it to cash out now and enjoy the gains, or keep holding and use it as a fun little extra to watch and pay attention to.

Options, though, confuse the heck out of me. Part of me says that I should be able to learn and maybe use them, but there's another part of me that doesn't want to learn lest I enjoy them too much, and just stick with basic buying and selling.
 
I still have my ETH that I bought a while ago. Not sure whether it's worth it to cash out now and enjoy the gains, or keep holding and use it as a fun little extra to watch and pay attention to.

Options, though, confuse the heck out of me. Part of me says that I should be able to learn and maybe use them, but there's another part of me that doesn't want to learn lest I enjoy them too much, and just stick with basic buying and selling.
My experience with options has been I'm better off using them as a long term leveraged position like LEAPS, instead of short term dice rolls. They are so dangerous and can murder your account in a hurry, especially if you have early success and think you're super smart lol. As CH said, they are also can provide short term insurance through puts for your long term holdings if the stock market tanks.
 
Neat podcast with Pomp and Saifedean Ammous on his new book coming out (the fiat standard), talking about shorting fiat:

 
Any stock you buy is shorting fiat; ie you buy AAPL because you think it will outperform cash
 
FSLY quickly recovered all of its post earnings dive. Shorts got greedy.
 

Hey look weed companies still make money. 1.25b annual run rate. Profitability metrics obviously not in line with peers but overall these are big boy numbers. Big growth and a nice beat. They usually provide next quarter guidance on their call so I'll be back to report that!


Verano tomorrow morning, clashing with an enormous share unlock that the shorts have been running with for weeks. Curious to see how that plays out. ~$200m in revenues (50% qoq growth) is likely there.
 
  • Like
Reactions: CH1

Hey look weed companies still make money. 1.25b annual run rate. Profitability metrics obviously not in line with peers but overall these are big boy numbers. Big growth and a nice beat. They usually provide next quarter guidance on their call so I'll be back to report that!


Verano tomorrow morning, clashing with an enormous share unlock that the shorts have been running with for weeks. Curious to see how that plays out. ~$200m in revenues (50% qoq growth) is likely there.
Bojo sees 2021 revenue at $1.2-1.3b. Around double what they achieved in 2020. With NY and NJ on the horizon I suspect there could be another doubling when they're both online.

So we're looking at 628m-728m in the final two quarters.
 
@CH1 your old friend up to its old tricks. ARCT up 31% after earnings and almost 100% in a month or so.




other vaccine names have also gone apeshit

sadly, I did not hold a runner in MRNA


screen-shot-2021-08-09-at-7-00-16-pm-png.9859
 

Attachments

  • Screen Shot 2021-08-09 at 7.00.16 PM.png
    Screen Shot 2021-08-09 at 7.00.16 PM.png
    167.6 KB · Views: 37
other vaccine names have also gone apeshit

sadly, I did not hold a runner in MRNA


screen-shot-2021-08-09-at-7-00-16-pm-png.9859
The tesla of biotech. Fundamentally overvalued by just about every metric. Heavily shorted, angry angry shorts all over the twitters, etc. A fun story.
 
Verano tomorrow morning, clashing with an enormous share unlock that the shorts have been running with for weeks. Curious to see how that plays out. ~$200m in revenues (50% qoq growth) is likely there.
Did 199m which is well above analyst estimates (but in line with mine). Profitability tanked on first glance but due to several IFRS accounting impacts from their m&a action, they had a bunch of 1 time adjustments on the record that made things look a touch worse than they were. These issues will be long gone by the end of the year. They also mentioned that they will not raise cash by diluting the stock; they will find non-dilutive ways to do this if required. That's a big boy move. Less of a need to raise cash anyway when your Cap Ex is self funded by cash from operations.

They have guided for a 1.1b annual run rate by Q4 which is $275m and have promised a return to their signature EBITDA profile. 38% growth; and better if NJ adult use sales begin in Q4. Relatively in line with Green Thumb with similar balance sheets and better profitability, albeit with no NY presence (Thumb deserves a premium for this reason). However, at the moment Thumb's market cap is around 3b higher than theirs. It's aggressive. They're both "cheap" tho.
 
  • Like
Reactions: CH1
Share unlock on Verano is today so I'm expecting and even hoping for volatility. I would like to accumulate after taking a bunch off the top on the pop the other day.
 
Back
Top